At Booth #1100, Zimmer Biomet will display the Z1 and G7 systems, along with HAMMR, OrthoGrid Hip AI and its mixed reality and robotic technologies for hip procedures.

Zimmer Biomet is recalling the CPT Hip System and plans to discontinue it by December 2024 due to safety concerns raised by the FDA. Get ahead of Wall Street reactions—Benzinga Pro delivers ...

The Monogram acquisition will contribute to revenue growth in 2027 by improving Zimmer Biomet's robotic knee adoption in the U.S.

Zimmer Biomet said the hip system’s label would be amended to include clinical findings that its implant recorded a fracture rate of about 1.4% during its use in the U.K., versus rates between ...

By Connor Hart The Food and Drug Administration said hip replacement surgeries that use Zimmer Biomet's CPT Hip System result in a higher risk of thigh bone fracture. The agency on Tuesday said ...

Zimmer Biomet's sales are up 4% to $1.82 billion. Knee and hip products grew, while 2024 EPS guidance was slightly lowered.

Zimmer Biomet Holdings, Inc. ZBH recently announced the signing of a definitive agreement to acquire OrthoGrid Systems, Inc., a privately-held medical technology company focused on artificial ...

Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction ...

Oct 30 (Reuters) - Hip implant maker Zimmer Biomet (ZBH.N), opens new tab lowered its annual profit forecast on Wednesday following last month's disruptions to a software platform that was ...